Article
-141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population.
American journal of medical genetics - 20 Aug 1999
Breen G, Brown J, Maude S, Fox H, Collier D, Li T, Arranz M, Shaw D, StClair D
Abstract excerpt
Dopamine has long been hypothesised to be involved in the pathogenesis of schizophrenia. The dopamine D2 receptor is a major site of action of neuroleptic agents used in the treatment of schizophrenia. Arinami et al. [1997; Human Mol Genet 6:577-582] have recently sequenced the dopamine receptor 2 (DRD2) gene in Japanese individuals and identified a novel polymorphism: a single cytosine deletion at position -141...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
